nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00304	0.00304	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Fesoterodine—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Fesoterodine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Fesoterodine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Fesoterodine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Fesoterodine—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Fesoterodine—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Fesoterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Fesoterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Fesoterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Fesoterodine—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00211	0.00211	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00203	0.00203	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00198	0.00198	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Fesoterodine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Fesoterodine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Fesoterodine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Fesoterodine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00163	0.00163	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Fesoterodine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Fesoterodine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Fesoterodine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CHKB—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.00119	0.00119	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PENK—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000983	0.000983	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00097	0.00097	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PENK—narcolepsy	0.00097	0.00097	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000949	0.000949	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000946	0.000946	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000937	0.000937	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000933	0.000933	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000933	0.000933	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00093	0.00093	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00093	0.00093	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000921	0.000921	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000921	0.000921	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000901	0.000901	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—TNF—narcolepsy	0.0009	0.0009	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000898	0.000898	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00089	0.00089	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000862	0.000862	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000861	0.000861	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.000859	0.000859	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CPT1B—narcolepsy	0.000859	0.000859	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000851	0.000851	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000837	0.000837	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000835	0.000835	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000825	0.000825	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000815	0.000815	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CHKB—narcolepsy	0.000802	0.000802	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000786	0.000786	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000786	0.000786	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000784	0.000784	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000784	0.000784	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000776	0.000776	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000776	0.000776	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000766	0.000766	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000764	0.000764	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000756	0.000756	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000755	0.000755	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000755	0.000755	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000723	0.000723	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000714	0.000714	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000714	0.000714	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000712	0.000712	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000712	0.000712	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000705	0.000705	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000705	0.000705	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.000702	0.000702	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000683	0.000683	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000681	0.000681	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000674	0.000674	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000672	0.000672	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.000637	0.000637	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000626	0.000626	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000626	0.000626	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.00061	0.00061	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000599	0.000599	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000599	0.000599	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000581	0.000581	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000573	0.000573	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CPT1B—narcolepsy	0.000545	0.000545	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000513	0.000513	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000509	0.000509	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000508	0.000508	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000503	0.000503	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000494	0.000494	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000473	0.000473	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000472	0.000472	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000467	0.000467	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000444	0.000444	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.00043	0.00043	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000428	0.000428	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000424	0.000424	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000422	0.000422	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000422	0.000422	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000416	0.000416	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000416	0.000416	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000376	0.000376	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.00036	0.00036	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000336	0.000336	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000254	0.000254	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000253	0.000253	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000251	0.000251	CbGpPWpGaD
